Abstract
Androgens are considered beneficial for athletic performance by potent anabolic effects on muscle mass and bone tissue. Testosterone also increases the formation of new blood cells and circulating hemoglobin, which will enhance oxygen uptake. Furthermore, androgens may exert behavioral and psychological effects of importance for athletic performance including increased mental drive and competitiveness. Studies in men have shown dose–dependent relationship between circulating testosterone with muscle mass and strength, as well as circulating hemoglobin. Experimental evidence in women is much more limited. However, recent studies in nonathletic and athletic women have demonstrated associations between endogenous testosterone levels, muscle mass, and muscle strength. Furthermore, it has been demonstrated that women with mild hyperandrogenism like polycystic ovary syndrome (PCOS) are overrepresented in elite athletes. PCOS, which has a genetic component, is associated with an anabolic body composition, and this syndrome may therefore confer an advantage for physical performance and could play a role in the recruitment of women to competitive sport activities. The prevalence of severe hyperandrogenism, such as disorders of sex development (DSD), is also increased among female athletes. DSD may cause a greatly increased production of testosterone in the male range. These results support a significant role of endogenous androgens for athletic performance in women.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Longcope C. Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 1986;15(2):213–28.
Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3–5.
Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847–53.
Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab. 1981;53(1):58–68.
Labrie F, Martel C, Belanger A, Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. J Steroid Biochem Mol Biol. 2017;168:9–18.
Pretorius E, Arlt W, Storbeck KH. A new dawn for androgens: novel lessons from 11-oxygenated C19 steroids. Mol Cell Endocrinol. 2017;441:76–85.
Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care. 2004;7:271–7.
Manttari S, Anttila K, Jarvilehto M. Testosterone stimulates myoglobin expression in different muscles of the mouse. J Comp Physiol B. 2008;178:899–907.
Auyeung TW, Lee JS, Kwok T, Leung J, Ohlsson C, Vandenput L, Leung PC, Woo J. Testosterone but not estradiol level is positively related to muscle strength and physical performance independent of muscle mass: a cross-sectional study in 1489 older men. Eur J Endocrinol. 2011;164(5):811–7.
Bosco C, Tihanyi J, Viru A. Relationships between field fitness test and basal serumtestosterone and cortisol levels in soccer players. Clin Physiol. 1996;16(3):317–22.
Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW. Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab. 2001;281:E1172–81.
Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, Jones BF, Barry CV, Wulczyn KE, Thomas BJ, Leder BZ. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369:1011–22.
van Geel TACM, Geusens PP, Winkens B, Sels JPJE, Dinant G-J. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol. 2009;160:681–7.
Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol. 2009;161:583–9.
Huang G, Basaria S, Travison TG, Ho MH, Davda M, Mazer NA, Miciek R, Knapp PE, Zhang A, Collins L, Ursino M, Appleman E, Dzekov C, Stroh H, Ouellette M, Rundell T, Baby M, Bhatia NN, Khorram O, Friedman T, Storer TW, Bhasin S. Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause. 2014;21:612–23.
Almeida M, Laurent MR, Dubois V, Claessens F, O’Brien CA, Bouillon R, Vanderschueren D, Manolagas SC. Estrogens and androgens in skeletal physiology and pathophysiology. Physiol Rev. 2017;97:135–87.
Notelovitz M. Androgen effects on bone and muscle. Fertil Steril. 2002;77(Suppl 4):S34–41.
Zborowski JV, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Bone mineral density, androgens and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone. J Clin Endocrinol Metab. 2000;85:3496–506.
Steinberg KK, Freni-Titulaer LW, DePuey EG, Miller DT, Sgoutas DS, Coralli CH, Phillips DL, Rogers TN, Clark RV. Sex steroids and bone density in premenopausal and perimenopausal women. J Clin Endocrinol Metab. 1989;69:533–9.
Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol. 2001;98:445–9.
Hirschberg AL. Sex hormones, appetite and eating behaviour in women. Maturitas. 2012;71:248–56.
Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes (Lond). 2008;32:1764–79.
Shahani S, Braga-Basaria M, Maggio M, Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest. 2009;32:704–16.
Bachman E, Travison TG, Basaria S, Davda MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V, Bhasin S. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014;69:725–35.
Ekblom B, Goldbarg AN, Gullbring B. Response to exercise after blood loss and reinfusion. J Appl Physiol. 1972;33:175–80.
Wood RI, Stanton SJ. Testosterone and sport: current perspectives. Horm Behav. 2012;61:147–55.
Bröder A, Hohmann N. Variations in risk taking behavior over the menstrual cycle: an improved replication. Evol Hum Behav. 2003;24:391–8.
Lewin C, Wolgers G, Herlitz A. Sex differences favoring women in verbal but not in visuospatial episodic memory. Neuropsychology. 2001;15:165–73.
Franke WW, Berendonk B. Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem. 1997;43(7):1262–79.
IAAF List of athletes currently serving a period of ineligibility as a result of an anti-doping rule violation under IAAF rules. https://www.iaaf.org/about-iaaf/documents/anti-doping.
Goldman A, Basaria S. Adverse health effects of androgen use. Mol Cell Endocrinol. 2018;15:464:46–55.
Cardinale M, Stone MH. Is testosterone influencing explosive performance? J Strength Cond Res. 2006;20(1):103–7.
Bermon S, Garnier PY. Serum androgen levels and their relation to performance in track and field: mass spectrometry results from 2127 observations in male and female elite athletes. Br J Sports Med. 2017;51(17):1309–14.
Eklund E, Berglund B, Labrie F, Carlström K, Ekström L, Hirschberg AL. Serum androgen profile and physcial performance in women olympic athletes. Br J Sports Med. 2017;51(17):1301–8.
Rickenlund A, Carlström K, Ekblom B, Brismar T, von Schoultz B, Hirschberg AL. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea and amenorrhea in female athletes and may improve physical performance. Fertil Steril. 2003;79:947–55.
Rickenlund A, Thorén M, Carlström K, von Schoultz B, Hirschberg AL. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab. 2004;89:702–7.
Hagmar M, Berglund B, Brismar K, Hirschberg AL. Hyperandrogenism may explain reproductive dysfunction in female Olympic athletes. Med Sci Sports Exerc. 2009;41:1241–8.
Coste O, Paris F, Galtier F, Letois F, Maïmoun L, Sultan C. Polycystic ovary-like syndrome in adolescent competitive swimmers. Fertil Steril. 2011;96:1037–42.
Javed A, Kashyap R, Lteif AN. Hyperandrogenism in female athletes with functional hypothalamic amenorrhea: a distinct phenotype. Int J Women’s Health. 2015;7:103–11.
Turpeinen U, Linko S, Itkonen O, Hämäläinen E. Determination of testosterone in serum by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest. 2008;68:50–7.
Bermon S, Garnier PY, Hirschberg AL, Robinson N, Giraud S, Nicoli R, Baume N, Saugy M, Fénichel P, Bruce SJ, Henry H, Dollé G, Ritzen M. Serum androgen levels in elite female athletes. J Clin Endocrinol Metab. 2014;99:4328–35.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 International Society of Gynecological Endocrinology
About this chapter
Cite this chapter
Linden-Hirschberg, A. (2019). The Role of Androgens for Body Composition and Physical Performance in Women. In: Berga, S., Genazzani, A., Naftolin, F., Petraglia, F. (eds) Menstrual Cycle Related Disorders. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-030-14358-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-14358-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-14357-2
Online ISBN: 978-3-030-14358-9
eBook Packages: MedicineMedicine (R0)